|
Vaccine industry immune to the global slowdown!
As the rest of the world laid off factory workers and institute factories shut down, Pfizer
acquired Wyeth, resulting in one of the most diversified companies in the global health care industry. In Asia, numerous biopharmaceutical firms are increasing their investment into the vaccine business and striving to develop new product pipelines, gearing up their global competitiveness.
As 2009 rolls in, the world braces for impact as the worst fi nancial crisis in decades sends many industries reeling from the effects of a global economic slowdown. Surprisingly, the vaccine industry has not only ended 2008 in a very stable state but has entered 2009 poised for unprecedented growth. It is predicted that the global vaccine market is projected to reach US$21.05 Billion by 2010 from US$11.42 Billion in 2006.
This is the best time to be in the Asian vaccine industry! It’s a region where many governments are becoming more and more aware of the importance of immunization. As a result, they are diverting resources to address this growing need. Also, a cost-effective labour base coupled with a rich talent pool sustains profi tability. Asian manufacturers are on their way to becoming more attractive business partners because of their increasing competitiveness globally.
Despite this, Asia is not without its own drawbacks. For global manufacturers, each country requires a
different approach when introducing new vaccines. Delays are caused by the fragmented and non-homogenous nature of its regulatory environment. Marketing and distribution strategies also have to
be attuned to the dynamics of each country. Asian manufacturers face obstacles in adhering to global
standards, accessing the latest technology and ensuring high quality. These serve as barriers for
them to expand globally.
World Vaccine Congress Asia will bridge these gaps by bringing together global and regional vaccine buyers and sellers, regulators, investors, technology and service providers to discuss best business strategies in accessing different vaccine markets in Asia and forging strategic partnerships for international success.
In this 4-day event, an unprecedented line-up of leaders from many of the world’s top players will
convene to share knowledge, discover innovative business models and form lasting relationships that will benefi t your company longer than this event will. Don’t be left out and don’t be left behind.
» Reserve your seat now!
|
